3-150927631-T-TAC
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BA1
The NM_174878.3(CLRN1):c.*304_*305insGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.024 ( 80 hom., cov: 0)
Exomes 𝑓: 0.012 ( 2 hom. )
Consequence
CLRN1
NM_174878.3 3_prime_UTR
NM_174878.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.454
Genes affected
CLRN1 (HGNC:12605): (clarin 1) This gene encodes a protein that contains a cytosolic N-terminus, multiple helical transmembrane domains, and an endoplasmic reticulum membrane retention signal, TKGH, in the C-terminus. The encoded protein may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIIa. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 3-150927631-T-TAC is Benign according to our data. Variant chr3-150927631-T-TAC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 343807.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=2}.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0531 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLRN1 | NM_174878.3 | c.*304_*305insGT | 3_prime_UTR_variant | 3/3 | ENST00000327047.6 | NP_777367.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLRN1 | ENST00000327047.6 | c.*304_*305insGT | 3_prime_UTR_variant | 3/3 | 1 | NM_174878.3 | ENSP00000322280 | P1 | ||
CLRN1 | ENST00000295911.6 | c.342+433_342+434insGT | intron_variant | 1 | ENSP00000295911 | |||||
ENST00000469268.1 | n.235+36789_235+36790dup | intron_variant, non_coding_transcript_variant | 4 | |||||||
CLRN1-AS1 | ENST00000476886.5 | n.123+75053_123+75054dup | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0242 AC: 3600AN: 148690Hom.: 80 Cov.: 0
GnomAD3 genomes
AF:
AC:
3600
AN:
148690
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0133 AC: 1325AN: 99722Hom.: 1 AF XY: 0.0133 AC XY: 722AN XY: 54260
GnomAD3 exomes
AF:
AC:
1325
AN:
99722
Hom.:
AF XY:
AC XY:
722
AN XY:
54260
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0119 AC: 3854AN: 323720Hom.: 2 Cov.: 0 AF XY: 0.0115 AC XY: 2082AN XY: 180926
GnomAD4 exome
AF:
AC:
3854
AN:
323720
Hom.:
Cov.:
0
AF XY:
AC XY:
2082
AN XY:
180926
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0243 AC: 3614AN: 148802Hom.: 80 Cov.: 0 AF XY: 0.0260 AC XY: 1885AN XY: 72438
GnomAD4 genome
AF:
AC:
3614
AN:
148802
Hom.:
Cov.:
0
AF XY:
AC XY:
1885
AN XY:
72438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Retinitis pigmentosa-deafness syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Retinitis Pigmentosa, Dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 26, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at